NCT00859339 Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC Status TERMINATED Phase PHASE2
NCT00847015 Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE2
NCT00846027 A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00844688 Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2
NCT00844649 Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3
NCT00842712 Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00837031 Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas Status COMPLETED Phase PHASE2
NCT00832637 Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers Status TERMINATED Phase PHASE2
NCT00828841 Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC Status COMPLETED Phase PHASE2
NCT00813696 Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE3
NCT00811993 A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00810719 Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00806923 A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT00789763 Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma Status COMPLETED Phase PHASE1
NCT00789633 Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00783172 Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT00779584 A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) Status COMPLETED Phase PHASE1